Home GeneSys

GeneSys

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Detailing – Sales Presentation – An art of Effective Communication

April 18, 2020

Leaves – Types and Details

April 16, 2020

Roles and Responsibilities of Product Manager – Pharma Industry

November 8, 2020

HOT NEWS

New Drug Approval

New Drug Approval | FDA Approves Colchicine (Lodoco) as First Anti-Inflammatory...

Role and Responsibilities

DCR Analysis – Job of Area Manager

Interview Questions

Interview Preparation Area Manager – Free Webinar

Learning and Development